1Dauer W,Predborski S.Parkinson's disease:mechanisms and models[J].Neuron,2003,39,889-909.
2Andersen JK.Does neuronal loss in Parkinson's disease involve programmed cell death?[J].Bioessays,2001,23(7):640-646.
3Zimmermann KC,Bonzon C,Green DR.The machinery of programmed cell death[J].Pharmacol Ther,2001,92:57-70.
4Ly JD,Grubb D,Lawen R.The mitochondrial membrane potential (△ψm) in apoptosis ; an update[J].Apoptosis,2003,8:115-128.
5Green DR,Kroemer G.The pathophysiology of mitochondrial cell death[J].Science,2004,305(5684):626-629.
6Schapira AH,Mann VM,Cooper JM,et al.Anatomic and disease specificity of NADH CoQ1 reductase complex Ⅰ deficiency in Parkinson's desease[J].J Neurochem,1990,55:2142-2145.
7Bindoff LA,Birch-Machin MA,Cartlidge NE,et al.Respiratory chain abnormalties in skeletal muscle from patients with Parkinson's Disease[J].J Neurol Sci,1991,104(2):203-208.
8Benecke R,Szrumper P,Weiss H.Electron transfer complexes Ⅰ and Ⅳ of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes[J].Brain,1993,116:1451-1463.
9Bonifatio V.Genetics of Parkinson's disease[J].Minerva Med,2005,96(3):175-186.
